Ulcerative colitis: open trials in Croatia

13 open trials have a site in Croatia. Registry data; only the trial team decides who can take part.

NCT07415044
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 2 · Eli Lilly and Company
Opca bolnica Bjelovar, Bjelovar · Poliklinika Borzan, Osijek · Klinički Bolnički Centar Split, Split · Klinicki Bolnicki Centar Zagreb, Zagreb
Registry updated 2026-11-04
NCT07652294
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Trial Treatment · Phase 2 · Spyre Therapeutics, Inc.
Poliklinika Borzan d.o.o., Osijek · University Hospital Centre Zagreb, Zagreb
Registry updated 2026-11-03
NCT06619990
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Trial Treatment · Phase 1/2 · Xencor, Inc.
Osijek · Rijeka · Zagreb
Registry updated 2026-10-30
NCT07012395
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Trial Treatment · Phase 2 · Spyre Therapeutics, Inc.
Poliklinika Borzan d.o.o., Osijek · University Hospital Centre Zagreb, Zagreb
Registry updated 2026-10-27
2024-511458-32-00
A study evaluating the effects of filgotinib in children and teenagers with ulcerative colitis
Trial Treatment · Phase 3 · Alfasigma S.p.A.
Klinički bolnički centar Osijek, Osijek · University Hospital Centre Zagreb, Zagreb · Children's Hospital Zagreb, Zagreb
Registry updated 2026-10-26
2025-524404-29-00
A study of LY4268989 in participants with Moderately to Severely Active Ulcerative Colitis (EMERALD-3)
Trial Treatment · Phase 2 · Eli Lilly & Co.
Opca Bolnica Dr. Andelko Visic Bjelovar, Bjelovar · Poliklinika Borzan d.o.o., Osijek · University hospital of Split, Split · University Hospital Center Zagreb, Zagreb
Registry updated 2026-10-21
NCT06865417
A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Trial Treatment · Phase 3 · Alfasigma S.p.A.
Klinički bolnički centar Osijek, Osijek · University Hospital Centre Zagreb, Zagreb · Children's Hospital Zagreb, Zagreb
Registry updated 2026-10-20
NCT07857447
The Effects of a Modified Mediterranean Diet on Ulcerative Colitis Patients
Trial Treatment · University Hospital Sestre Milosrdnice
University Hospital Center Sestre milosrdnice, Zagreb
Registry updated 2026-10-05
2024-520201-39-00
A Phase 2a Study of the Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 2 · Odyssey Therapeutics Inc.
Clinical Hospital Dubrava, Grad Zagreb · Poliklinika Solmed d.o.o., Grad Zagreb · Poliklinika Borzan d.o.o., Osijek · KBC Split, Split
Registry updated 2026-07-31
2025-522001-38-00
A Phase 2 Platform Study to Evaluate Therapies for Inflammatory Bowel Disease
Trial Treatment · Phase 2 · Mirador Therapeutics Inc.
Poliklinika Solmed d.o.o., Grad Zagreb · Poliklinika Borzan d.o.o., Osijek · Specijalna Bolnica Medico, Rijeka · University Hospital Centre Zagreb, Zagreb
Registry updated 2026-07-20
NCT07662902
Ulcerative Colitis Permeability
Research · University Hospital Dubrava
University Hospital Dubrava, Zagreb
Registry updated 2026-06-25
NCT05442567
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Trial Treatment · Phase 3 · Takeda
Klinika Za Djecje Bolesti Zagreb, Grad Zagreb
Registry updated 2026-05-07
2023-507853-13-00
An Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone or in Combination with Mirikizumab for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis
Trial Treatment · Phase 2 · Eli Lilly & Co.
Opca Bolnica Dr. Andelko Visic Bjelovar, Bjelovar · Poliklinika Solmed d.o.o., Grad Zagreb · Poliklinika Borzan d.o.o., Osijek · Specijalna Bolnica Medico, Rijeka · General Hospital Dr. Josip Bencevic, Slavonski Brod · University Hospital Centre Zagreb, Zagreb
Registry updated 2026-04-01

All Ulcerative colitis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error